RCEL
AVITA Medical Inc
Price:  
8.37 
USD
Volume:  
175,949.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AVITA Stock Forecast & Price Target

AVITA Stock Price Forecast

The average stock forecast for AVITA Medical Inc (RCEL) in the next 12 months is 23.66 USD. This price target corresponds to an upside of 182.72%. The range of stock forecasts for AVITA is 9.09 - 42.00 USD. Based on the ratings of 14 analysts, the consensus recommendation for AVITA is BUY.
Target Low Average Median High
Price (USD) 9.09 23.66 21.42 42.00
Upside 8.60% 182.72% 155.91% 401.79%

Recommendation Trends

The latest consensus rating for AVITA is "BUY". This is the average recommendation of 14 analysts: 0 strong sell, 0 sell, 4 hold, 7 buy, 3 strong buy. In the previous period, 14 analysts also majorly recommmended "BUY" for AVITA.

AVITA Financial Stock Forecast

Revenue This Year
75.65M
50.88%
from 50.14M
Revenue Next Year
103.67M
37.03%
from 75.65M
EPS This Year
-1.44
5.26%
from -1.37
EPS Next Year
-0.75
-48.00%
from -1.44